Report: Omega 3 Can Lead to Societal Health Care Savings

omega 3 hookweb.jpg

13 Feb 2014 --- This February, in recognition of the 50th anniversary of American Heart Month, a new economic report brings awareness to the numerous benefits of omega-3 fatty acids for heart health. While these benefits are well-established for men and women in all stages of life, for U.S. adults over 55 with Coronary Heart Disease (CHD), the benefits extend beyond heart health, and into their wallets.

The report, “Smart Prevention—Health Care Cost Savings Resulting from the Targeted Use of Dietary Supplements,” conducted by Frost & Sullivan through a grant from the Council for Responsible Nutrition Foundation (CRNF), shows that if this targeted population, U.S. adults over the age of 55 with CHD, take omega-3 dietary supplements at the preventive intake levels identified in the report, it can lead to individual and societal health care savings.

“Our country is faced with a serious problem when it comes to sick care and rising health care costs,” said Steve Mister, president, CRNF. “Taking dietary supplements, such as omega-3s, is not a magic bullet by any means, but it’s one preventive measure that should be considered along with eating a healthy diet and exercising regularly to potentially help maintain a healthy heart. Given the costs of treating medical events that result from CHD, simple steps like this can help reduce health care costs, too.”

Omega-3s, the third most popular dietary supplement among U.S. adults 55 and older1, are the “good fats” that our bodies need to survive. Their essential role in the diet is recognized by authoritative bodies such as the American Heart Association, the World Health Organization, the U.S. Institute of Medicine’s Food and Nutrition Board and the 2010 Dietary Guidelines, all of which have current policies advising Americans to eat more fatty fish to get the benefits of omega-3 fish oils.

“Unfortunately most Americans are not eating enough fatty fish to reap the full benefits of omega-3s,” said Duffy MacKay, N.D., senior vice president, scientific and regulatory affairs, Council for Responsible Nutrition. “So omega-3 supplementation is a viable option, especially for anyone who doesn’t eat fatty fish, like salmon and sardines, regularly. Omega-3s help lower triglycerides and support healthy blood flow—two factors which play a role in coronary heart disease.”

According to the report, nearly $4 billion in cumulative net CHD-attributed cost savings from 2013 to 2020 is potentially realizable if the entire targeted population (U.S. adults over the age of 55 diagnosed with CHD) were to use omega-3 dietary supplements at preventive intake levels. This is the equivalent of more than one million hospital events avoided in the next seven years, the report stated. Additionally, the report identified that only 28 percent of the targeted population currently takes omega-3 supplements, meaning that 72 percent of the targeted population have yet to benefit.

To achieve the results, Frost & Sullivan conducted a systematic review of scientific research that focused on published studies that looked at the relationship between omega-3 supplementation and the risk of a CHD-attributed event and quantified the reduction in medical events attributed to that usage. The firm then projected the rates of CHD-attributed medical events across U.S. adults over the age of 55 with CHD and applied a cost benefit analysis to determine the cost savings if people in this targeted population took omega-3 supplements at preventive intake levels.

To contact our editorial team please email us at

Related Articles

Health & Nutrition News

Resilient in nutrition: DSM reports “very strong” 2018, reveals €1 billion buyback strategy

14 Feb 2019 --- DSM has reported a “very strong year,” including robust Q4 figures, organic sales growth of 6 percent and adjusted EBITDA up 26 percent, including €290 million (US$327 million) due to temporary exceptional vitamin effects. With Q4 core profit topping expectations, the company has announced that it will buy back €1 billion in shares.

Health & Nutrition News

“Applying the modern technology of AI to the ancient practice of food”: Nuritas exec

14 Feb 2019 --- Unlike traditional biotechs and academics that have searched for life’s panacea in exotic and rare places, Irish biotech company Nuritas is unlocking life-changing molecules in commonly consumed, everyday staple foods. This is according to Neil Foster, Head of Strategic Partnerships at Nuritas, who spoke to NutritionInsight on the company’s expanding partnership list and how it’s pushing the innovation boat further than ever before.

Health & Nutrition News

Algatech launches potent astaxanthin in whole-food format

11 Feb 2019 --- Israeli-based Algatechnologies has launched AstaPure Arava, an all-natural, algae complex that contains naturally occurring constituents of the Haematococcus Pluvialis algae. The company claims that this species of microalgae is the “richest known source of astaxanthin” and its properties are supported by research from NIS Labs, a research institute based in the US. Led by Dr. Gitte Jensen, the research has shown that Arava algae powder is highly potent and has the synergistic effects of natural astaxanthin and the whole-algae complex.

Health & Nutrition News

Fermentalg to “ramp up” omega 3 platform following strong growth in 2018

11 Feb 2019 --- Microalgae innovator Fermentalg has reported accelerated industrial and commercial growth across three of its major platforms for the 2018 period, particularly regarding its foray into premium omega 3. The other platforms include protein and pigments and its algal biofilter. The success has placed the company in a prime position to “ramp up its business” in 2019 on the omega 3 platform, according to Fermentalg.

Health & Nutrition News

Rapeseed study paves way for use as an alternative protein source

07 Feb 2019 --- Rapeseed’s potential as a high-quality protein source has often been overlooked because of the seed’s intense bitter taste. This bitter taste has prohibited its use in food applications – until now. A team of researchers from the Technical University of Munich (TUM) has identified the substance responsible for rapeseed’s bitterness. The discovery could signal the development of rapeseed as an important protein source suitable for human consumption.

More Articles